Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

KIT (KIT proto-oncogene, receptor tyrosine kinase)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

Guardant360® CDx (54)

MSK-IMPACT (21)

Oncomine™ Dx Target Test (11)

FoundationOne® Heme CDx (10)

TruSeq®Amplicon - Cancer Panel (5)

Oncomine™ Pan-Cancer Cell-Free Assay (4)

TruSight Oncology 500 Assay (3)

Guardant360 TissueNext™ (2)

Dako c-KIT pharmDx (1)

AVENIO Tumor Tissue CGP Kit

AVENIO Tumor Tissue Surveillance Kit

AVENIO Tumor Tissue Targeted Kit

AVENIO ctDNA Expanded Kit

AVENIO ctDNA Surveillance Kit

AVENIO ctDNA Targeted Kit

AmoyDx® C-KIT Mutation Detection Kit

AmoyDx® HANDLE Classic NGS Panel

AnchorAIM® 72 gene detection for individualized treatment of solid tumors

Archer® FusionPlex® Oncology Research Kit

Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit

Archer® VariantPlex® Myeloid panel

Archer® VariantPlex® Solid Tumor Kit

Archer™ FusionPlex™ Core Solid Tumor Panel

Archer™ VARIANTPlex™ Complete Solid Tumor panel

Archer™ VARIANTPlex™ Pan Solid Tumor panel

CancerNext-Expanded®

CustomNext-Cancer®

DecisionDx®-CMSeq

FusionPlex™ Pan-Heme panel

GALEAS™ Hereditary Plus

Invitae Common Hereditary Cancers Panel

Labcorp® Plasma Complete™

Labcorp® Plasma Focus™

LiquidHALLMARK®

Myeloid Molecular Profile

NGS Targeted Hotspot Panel

NeXT Dx™ Test

NeoLAB® Solid Tumor Liquid Biopsy

NeoTYPE® Lung Tumor Profile

Northstar Select™

NovoFocus™ CRC 2.0

NovoFocus™ NSCLC 2.0 Test

OncoGuide™ NCC Oncopanel System

OncoKey™ SL 525 Plus Assay

OncoKey™ SL 60 Plus Assay

OncoPanel™ Assay

OncoScreen™ Focus CDx Tissue Kit

Oncomine Focus Assay

Oncomine Precision Assay

Oncomine™ Myeloid MRD Assays

OptiSeq™ Lung Cancer Panel

OptiSeq™ Pan-Cancer Gene Panel

PGDx elio® plasma focus™ Dx

PGDx elio™ plasma resolve assay

SOPHiA DDM™ Myeloid Solution

SOPHiA DDM™ Solid Tumor Plus Solution

SOPHiA Myeloid Plus Solution

SafeSEQ AML MRD Assay

StrataNGS™ Test

SureSeq™ Myeloid MRD Panel

SureSeq™ Pan-Myeloid Panel

Tempus xF Assay

Tempus xF+ Panel

TruSight Myeloid Sequencing Panel

TruSight Oncology Comprehensive

TruSight Tumor 15 Assay

UltraSEEK® Melanoma Panel

VarMap™ Pan-Cancer NGS Panel

Vartrace® AML Panel

oncoReveal™ Core LBx

oncoReveal™ Essential LBx

oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel

oncoReveal™ Solid Tumor v2 Panel

Guardant360® CDx (54)

MSK-IMPACT (21)

Oncomine™ Dx Target Test (11)

FoundationOne® Heme CDx (10)

TruSeq®Amplicon - Cancer Panel (5)

Oncomine™ Pan-Cancer Cell-Free Assay (4)

TruSight Oncology 500 Assay (3)

Guardant360 TissueNext™ (2)

Dako c-KIT pharmDx (1)

AVENIO Tumor Tissue CGP Kit

AVENIO Tumor Tissue Surveillance Kit

AVENIO Tumor Tissue Targeted Kit

AVENIO ctDNA Expanded Kit

AVENIO ctDNA Surveillance Kit

AVENIO ctDNA Targeted Kit

AmoyDx® C-KIT Mutation Detection Kit

AmoyDx® HANDLE Classic NGS Panel

AnchorAIM® 72 gene detection for individualized treatment of solid tumors

Archer® FusionPlex® Oncology Research Kit

Archer® VariantPlex® Comprehensive Thyroid and Lung (CTL) kit

Archer® VariantPlex® Myeloid panel

Archer® VariantPlex® Solid Tumor Kit

Archer™ FusionPlex™ Core Solid Tumor Panel

Archer™ VARIANTPlex™ Complete Solid Tumor panel

Archer™ VARIANTPlex™ Pan Solid Tumor panel

CancerNext-Expanded®

CustomNext-Cancer®

DecisionDx®-CMSeq

FusionPlex™ Pan-Heme panel

GALEAS™ Hereditary Plus

Invitae Common Hereditary Cancers Panel

Labcorp® Plasma Complete™

Labcorp® Plasma Focus™

LiquidHALLMARK®

Myeloid Molecular Profile

NGS Targeted Hotspot Panel

NeXT Dx™ Test

NeoLAB® Solid Tumor Liquid Biopsy

NeoTYPE® Lung Tumor Profile

Northstar Select™

NovoFocus™ CRC 2.0

NovoFocus™ NSCLC 2.0 Test

OncoGuide™ NCC Oncopanel System

OncoKey™ SL 525 Plus Assay

OncoKey™ SL 60 Plus Assay

OncoPanel™ Assay

OncoScreen™ Focus CDx Tissue Kit

Oncomine Focus Assay

Oncomine Precision Assay

Oncomine™ Myeloid MRD Assays

OptiSeq™ Lung Cancer Panel

OptiSeq™ Pan-Cancer Gene Panel

PGDx elio® plasma focus™ Dx

PGDx elio™ plasma resolve assay

SOPHiA DDM™ Myeloid Solution

SOPHiA DDM™ Solid Tumor Plus Solution

SOPHiA Myeloid Plus Solution

SafeSEQ AML MRD Assay

StrataNGS™ Test

SureSeq™ Myeloid MRD Panel

SureSeq™ Pan-Myeloid Panel

Tempus xF Assay

Tempus xF+ Panel

TruSight Myeloid Sequencing Panel

TruSight Oncology Comprehensive

TruSight Tumor 15 Assay

UltraSEEK® Melanoma Panel

VarMap™ Pan-Cancer NGS Panel

Vartrace® AML Panel

oncoReveal™ Core LBx

oncoReveal™ Essential LBx

oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel

oncoReveal™ Solid Tumor v2 Panel

›

KIT positive	Gastrointestinal Stromal Tumor	KIT positive	Gastrointestinal Stromal Tumor	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
KIT expression	Gastrointestinal Stromal Tumor	KIT expression	Gastrointestinal Stromal Tumor	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
KIT mutation	Thymic Carcinoma	KIT mutation	Thymic Carcinoma	sunitinib Sensitive: A2 - Guideline sunitinib Sensitive : A2	sunitinib Sensitive: A2 - Guideline sunitinib Sensitive : A2
KIT exon 9 mutation	Gastrointestinal Stromal Tumor	KIT exon 9 mutation	Gastrointestinal Stromal Tumor	imatinib Resistant: A2 - Guideline imatinib Resistant : A2	imatinib Resistant: A2 - Guideline imatinib Resistant : A2
KIT mutation	Gastrointestinal Stromal Tumor	KIT mutation	Gastrointestinal Stromal Tumor	imatinib Sensitive: A2 - Guideline imatinib Sensitive : A2	imatinib Sensitive: A2 - Guideline imatinib Sensitive : A2
KIT exon 13 mutation	Melanoma	KIT exon 13 mutation	Melanoma	nilotinib Sensitive: A2 - Guideline nilotinib Sensitive : A2	nilotinib Sensitive: A2 - Guideline nilotinib Sensitive : A2
KIT mutation	Cutaneous Melanoma	KIT mutation	Cutaneous Melanoma	imatinib Sensitive: A2 - Guideline imatinib Sensitive : A2	imatinib Sensitive: A2 - Guideline imatinib Sensitive : A2
KIT mutation	Gastrointestinal Stromal Tumor	KIT mutation	Gastrointestinal Stromal Tumor	ripretinib Sensitive: B - Late Trials ripretinib Sensitive : B	ripretinib Sensitive: B - Late Trials ripretinib Sensitive : B
KIT exon 11 mutation	Gastric Cancer	KIT exon 11 mutation	Gastric Cancer	imatinib Sensitive: B - Late Trials imatinib Sensitive : B	imatinib Sensitive: B - Late Trials imatinib Sensitive : B
KIT exon 9 mutation	Gastric Cancer	KIT exon 9 mutation	Gastric Cancer	imatinib Resistant: B - Late Trials imatinib Resistant : B	imatinib Resistant: B - Late Trials imatinib Resistant : B
KIT exon 9 mutation	Gastrointestinal Stromal Tumor	KIT exon 9 mutation	Gastrointestinal Stromal Tumor	regorafenib Sensitive: B - Late Trials regorafenib Sensitive : B	regorafenib Sensitive: B - Late Trials regorafenib Sensitive : B
KIT exon 13 mutation	Melanoma	KIT exon 13 mutation	Melanoma	imatinib Sensitive: B - Late Trials imatinib Sensitive : B	imatinib Sensitive: B - Late Trials imatinib Sensitive : B